Onglyza MDL Awaiting Approval Status

Introduction

Another heart failure lawsuit filed recently now awaits a nod for from the U.S. Judicial Panel on Multidistrict Litigation for centralization of all federally-filed Onglyza and Kombiglyze XR lawsuits in a single U.S. District Court for coordinated pretrial proceedings. The number of lawsuits filed has already crossed 40 and is expected to eventually grow to include hundreds of similar cases.

The JPML was scheduled to hear oral arguments on January 25, 2018, to decide whether consolidation was necessary or not. The court records show more than 42 product liability lawsuits pending in the federal court system filed by individuals who developed congestive heart failure and other side effects of diabetes drug.

Comments

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Onglyza MDL Awaiting Approval Status